Market Cap 4.09B
Revenue (ttm) 45.56M
Net Income (ttm) -241.60M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -530.29%
Debt to Equity Ratio 0.00
Volume 746,400
Avg Vol 1,113,660
Day's Range N/A - N/A
Shares Out 112.63M
Stochastic %K 19%
Beta 0.02
Analysts Strong Sell
Price Target $42.42

Company Profile

NewAmsterdam Pharma Company N.V., a late-stage biopharmaceutical company, develops therapies to enhance patient care in populations with metabolic disease. It is developing obicetrapib, an oral low-dose cholesteryl ester transfer protein (CETP) inhibitor, that is in various clinical trials as a monotherapy and a combination therapy with ezetimibe for lowering LDL-C for cardiovascular diseases. The company also develops Obicetrapib which is in Phase 2a clinical trial for Alzheimer's disease. NewA...

Industry: Biotechnology
Sector: Healthcare
Phone: 31 35 206 2971
Address:
Gooimeer 2-35, Naarden, Netherlands
notreload_ai
notreload_ai Oct. 20 at 3:57 PM
$BOLT , $NAMS ... H.C. Wainwright initiates coverage on Bolt Biotherapeutics and NewAmsterdam Pharma with Buy ratings, highlighting innovative treatments in development. https://notreload.xyz/bolt-bio-newamsterdam-get-hc-wainwright-buy-ratings/
0 · Reply
Digger75
Digger75 Oct. 20 at 1:04 PM
$NAMS looking at the order flow over the past few weeks someone was buying big chunks above 40.00 now it gets upgraded hmm
0 · Reply
JarvisFlow
JarvisFlow Oct. 20 at 10:46 AM
HC Wainwright & Co. has adjusted their stance on NewAmsterdam Pharma Co ( $NAMS ), setting the rating to Buy with a target price of 52.
1 · Reply
BioTechHealthX
BioTechHealthX Oct. 19 at 6:19 AM
$NAMS NewAmsterdam Pharma rockets nearly 94% year-over-year as investors bet big on its late-stage cholesterol drug obicetrapib. https://biotechhealthx.com/biotech-news/newamsterdam-pharma-nams-soars-93-9-in-12-months/
0 · Reply
masonat
masonat Oct. 18 at 1:09 AM
$NAMS Alzheimer's biomarker data published. https://www.sciencedirect.com/science/article/pii/S227458072500336X
2 · Reply
newfguy
newfguy Oct. 17 at 3:31 PM
$NAMS the pause that refreshes
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 3:28 PM
Citigroup updates rating for NewAmsterdam Pharma Co ( $NAMS ) to Buy, target set at 42 → 50.
0 · Reply
masonat
masonat Oct. 16 at 10:18 PM
$NAMS The last time NAMS was randomly down 10%...one whole month ago. What happened after? Oh. Almost like you can't make any conclusions based on a single day's movement.
0 · Reply
___IFindKarma___
___IFindKarma___ Oct. 16 at 10:10 PM
$NAMS Another $28 to go. Down.
0 · Reply
YoloAlfred
YoloAlfred Oct. 16 at 9:51 PM
$NAMS It gets much worse.....
0 · Reply
Latest News on NAMS
NewAmsterdam Pharma to Host R&D Day on June 11, 2025

Jun 5, 2025, 8:00 AM EDT - 5 months ago

NewAmsterdam Pharma to Host R&D Day on June 11, 2025


NewAmsterdam Pharma: A Mispriced Bet On A Cholesterol Revolution

Feb 28, 2025, 10:48 AM EST - 8 months ago

NewAmsterdam Pharma: A Mispriced Bet On A Cholesterol Revolution


Top 3 Health Care Stocks That May Collapse This Quarter

Dec 11, 2024, 6:55 AM EST - 11 months ago

Top 3 Health Care Stocks That May Collapse This Quarter

ADPT FNA


Why Is NewAmsterdam Pharma Stock Trading Higher On Tuesday?

Dec 10, 2024, 11:14 AM EST - 11 months ago

Why Is NewAmsterdam Pharma Stock Trading Higher On Tuesday?


NewAmsterdam Pharma Announces 2024 Strategic Priorities

Jan 4, 2024, 8:00 AM EST - 1 year ago

NewAmsterdam Pharma Announces 2024 Strategic Priorities


Tessellate BIO Emerges from Stealth

Oct 17, 2023, 3:00 AM EDT - 2 years ago

Tessellate BIO Emerges from Stealth

REPL


notreload_ai
notreload_ai Oct. 20 at 3:57 PM
$BOLT , $NAMS ... H.C. Wainwright initiates coverage on Bolt Biotherapeutics and NewAmsterdam Pharma with Buy ratings, highlighting innovative treatments in development. https://notreload.xyz/bolt-bio-newamsterdam-get-hc-wainwright-buy-ratings/
0 · Reply
Digger75
Digger75 Oct. 20 at 1:04 PM
$NAMS looking at the order flow over the past few weeks someone was buying big chunks above 40.00 now it gets upgraded hmm
0 · Reply
JarvisFlow
JarvisFlow Oct. 20 at 10:46 AM
HC Wainwright & Co. has adjusted their stance on NewAmsterdam Pharma Co ( $NAMS ), setting the rating to Buy with a target price of 52.
1 · Reply
BioTechHealthX
BioTechHealthX Oct. 19 at 6:19 AM
$NAMS NewAmsterdam Pharma rockets nearly 94% year-over-year as investors bet big on its late-stage cholesterol drug obicetrapib. https://biotechhealthx.com/biotech-news/newamsterdam-pharma-nams-soars-93-9-in-12-months/
0 · Reply
masonat
masonat Oct. 18 at 1:09 AM
$NAMS Alzheimer's biomarker data published. https://www.sciencedirect.com/science/article/pii/S227458072500336X
2 · Reply
newfguy
newfguy Oct. 17 at 3:31 PM
$NAMS the pause that refreshes
0 · Reply
JarvisFlow
JarvisFlow Oct. 17 at 3:28 PM
Citigroup updates rating for NewAmsterdam Pharma Co ( $NAMS ) to Buy, target set at 42 → 50.
0 · Reply
masonat
masonat Oct. 16 at 10:18 PM
$NAMS The last time NAMS was randomly down 10%...one whole month ago. What happened after? Oh. Almost like you can't make any conclusions based on a single day's movement.
0 · Reply
___IFindKarma___
___IFindKarma___ Oct. 16 at 10:10 PM
$NAMS Another $28 to go. Down.
0 · Reply
YoloAlfred
YoloAlfred Oct. 16 at 9:51 PM
$NAMS It gets much worse.....
0 · Reply
tttggg
tttggg Oct. 16 at 8:31 PM
$NAMS well… today’s option flow quite bearish…. No idea what’s going on…..
0 · Reply
omar_progressivetrading
omar_progressivetrading Oct. 16 at 7:37 PM
$NAMS Someone tell @NewFguy - TTIIMMMBBBEERRR! 🫡🌓 Zealot! 🫠
2 · Reply
djohnson591
djohnson591 Oct. 16 at 7:31 PM
$ESPR We told these guys at $NAMS what was coming.
4 · Reply
newfguy
newfguy Oct. 16 at 5:19 PM
$NAMS BTFD
0 · Reply
RunnerSignals
RunnerSignals Oct. 15 at 6:00 PM
wild ride alert $INV $ORGN $MOBX $PHAT $NAMS went full rollercoaster today with big intraday swings
0 · Reply
Heliosphere
Heliosphere Oct. 15 at 4:48 PM
$ESPR $NAMS Let’s care about us! We are not on cloud9! Let them enjoy for now
0 · Reply
fortyeight
fortyeight Oct. 15 at 4:43 PM
$ESPR Shorts are piling into $NAMS, a rug pull is coming.
3 · Reply
prettyinscarlet
prettyinscarlet Oct. 15 at 4:04 PM
$NAMS Sweet sweet trading chart. I've been long since $17. Reached my target price already, but it looks like there is plenty juice left to squeeze with the upcoming acquisition. Loaded up on calls too
0 · Reply
BioTechHealthX
BioTechHealthX Oct. 15 at 12:49 PM
$NAMS NewAmsterdam Pharma rockets nearly 94% year-over-year as investors bet big on its late-stage cholesterol drug obicetrapib. https://biotechhealthx.com/biotech-news/newamsterdam-pharma-nams-soars-93-9-in-12-months/
0 · Reply
lsb1201030758
lsb1201030758 Oct. 14 at 6:17 PM
$NAMS Nobody writes anything about this winner that has doubled in the last 3 months.
1 · Reply
newfguy
newfguy Oct. 13 at 11:56 PM
$NAMS $40 AH. sweet
0 · Reply
thehivemindfund
thehivemindfund Oct. 13 at 10:49 PM
$NAMS What an ugly day. Price did a symmetrical round trip - rare "selling at top" signal. My puts are locked and loaded.
2 · Reply